Videos | Channels | Search |
Professor Bauer, CSO of Centogene, discusses the prospects for researchers exploring variants associated with rare diseases in the light of the new collaboration with QIAGEN, and how patients suffering from these diseases may ultimately benefit from this.
Visit qiagenbioinformatics.com
03:16 minutes
Tags: biochemistry, Centogene, clinical phenotypes, genetic, genetic diseases, QIAGEN, rare disease, rare diseases